NASDAQ:RELV Reliv' International (RELV) Stock Price, News & Analysis → Pentagon contract could send this $2 AI stock soaring (From Behind the Markets) (Ad) Free RELV Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$3.85▼$3.8550-Day Range$2.50▼$3.7352-Week Range$2.50▼$4.42VolumeN/AAverage Volume23,200 shsMarket Capitalization$6.72 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisCompetitorsSocial MediaStock AnalysisCompetitorsSocial Media Get Reliv' International alerts: Email Address Ad Behind the MarketsPentagon contract could send this $2 AI stock soaringWhenever the Department of Defense awards a major AI contract... Early investors could see dramatic returns virtually overnight. That's how my readers were able to cash in gains like 133% in just four months on C3.ai...Get all the info here >>> About Reliv' International Stock (NASDAQ:RELV)Reliv' International, Inc. develops and markets nutritional supplements that address basic nutrition, specific wellness needs, weight management, and sports nutrition. The company's basic nutritional supplements are formulated to provide a balanced and complete level of supplementation for the consumer. Its principal products include Reliv Classic, Reliv Now, Innergize!, and FibRestore along with LunaRich X capsules. The company markets and sells its products through a direct selling system of independent distributors in the United States, Australia, Austria, Canada, France, Germany, Indonesia, Ireland, Malaysia, Mexico, the Netherlands, New Zealand, the Philippines, and the United Kingdom. Reliv' International, Inc. was founded in 1988 and is headquartered in Chesterfield, Missouri.Read More Ad Behind the MarketsPentagon contract could send this $2 AI stock soaringWhenever the Department of Defense awards a major AI contract... Early investors could see dramatic returns virtually overnight. That's how my readers were able to cash in gains like 133% in just four months on C3.ai...Get all the info here >>> RELV Stock News HeadlinesApril 18, 2024 | finance.yahoo.comAgape ATP Corporation (ATPC)March 29, 2024 | morningstar.comNorth American Morning Briefing: Stocks Set for -2-April 23, 2024 | Behind the Markets (Ad)Pentagon contract could send this $2 AI stock soaringWhenever the Department of Defense awards a major AI contract... Early investors could see dramatic returns virtually overnight. That's how my readers were able to cash in gains like 133% in just four months on C3.ai...October 10, 2023 | finance.yahoo.comReliv Celebrates 35 Years of Nourishing the World and Introduces New Healthy Aging SystemsSeptember 16, 2022 | reuters.comReliance Naval and Engineering LtdJanuary 21, 2022 | nasdaq.comRELV Real-Time QuotesSee More Headlines Receive RELV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Reliv' International and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/15/2020Today4/23/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorConsumer Staples Industry Pharmaceutical Preparations Sub-IndustryN/A Current SymbolNASDAQ:RELV CUSIPN/A CIK768710 Webwww.reliv.com Phone636-537-9715FaxN/AEmployees91Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-440,000.00 Net Margins-0.61% Pretax MarginN/A Return on Equity-1.89% Return on Assets-1.31% Debt Debt-to-Equity Ratio0.05 Current Ratio1.70 Quick Ratio1.04 Sales & Book Value Annual Sales$35.06 million Price / Sales0.19 Cash Flow$0.09 per share Price / Cash Flow44.53 Book Value$6.36 per share Price / Book0.61Miscellaneous Outstanding Shares1,746,000Free FloatN/AMarket Cap$6.72 million OptionableNot Optionable Beta-0.10 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesMr. Robert L. Montgomery (Age 79)Co-Founder & Chairman Comp: $538.27kMr. Ryan A. Montgomery (Age 47)CEO & Director Comp: $218.89kMr. Thomas W. Pinnock III (Age 70)Pres of Sales & Marketing Comp: $342.38kMr. Steven D. Albright CPA (Age 59)CPA, Sr. VP & CFO Ms. Debra P. Bernardoni (Age 50)Sr. VP & COO Mr. Stephen M. Merrick (Age 79)Gen. Counsel & Sec. Mr. Donald E. Gibbons Jr. (Age 66)Sr. VP of US Sales Mr. R. Scott Montgomery (Age 51)Pres of Operations & International Mr. Kurt C. Wulff (Age 56)Sr. VP of Marketing Ms. Susan R. StoneManaging Director of Reliv Asia PacificMore ExecutivesKey Competitors22nd Century GroupNASDAQ:XXIISteakholder FoodsNASDAQ:STKHFarmmiNASDAQ:FAMIBranchOut FoodNASDAQ:BOFDAVIDsTEANASDAQ:DTEAView All Competitors RELV Stock Analysis - Frequently Asked Questions How were Reliv' International's earnings last quarter? Reliv' International, Inc. (NASDAQ:RELV) released its quarterly earnings data on Friday, May, 15th. The company reported $0.38 earnings per share for the quarter. The business earned $10.28 million during the quarter. Reliv' International had a negative trailing twelve-month return on equity of 1.89% and a negative net margin of 0.61%. What is Ryan Montgomery's approval rating as Reliv' International's CEO? 1 employees have rated Reliv' International Chief Executive Officer Ryan Montgomery on Glassdoor.com. Ryan Montgomery has an approval rating of 100% among the company's employees. This puts Ryan Montgomery in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Reliv' International own? Based on aggregate information from My MarketBeat watchlists, some companies that other Reliv' International investors own include VIVUS (VVUS), Aquestive Therapeutics (AQST), Putnam Premier Income Trust (PPT), Rite Aid (RAD), RadNet (RDNT), Rexahn Pharmaceuticals (REXN), Rigel Pharmaceuticals (RIGL), RTI Surgical (RTIX), Sonoma Pharmaceuticals (SNOA) and Sunesis Pharmaceuticals (SNSS). This page (NASDAQ:RELV) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersPentagon contract could send this $2 AI stock soaringBehind the MarketsThe A.I. story nobody is telling you (Read ASAP)TradeSmithHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Reliv' International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
